Clinical trial
Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral…
NCT00090376 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00090376 |
|---|---|
| Title | Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy |
| Official title | Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 3 Arm, 12-Month Study to Evaluate the Effects of GPI 1485 on Erectile Function in Patients Undergoing Bilateral Nerve-Sparing Radical Retropubic Prostatectomy for Prostatic Carcinoma |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | Symphony Neuro Development Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Impotence, Prostate Cancer |
| Intervention type | Drug |
| Interventions | GPI 1485 |
| Enrollment | 240 |
| Start date | Dec 1, 2003 |
| First posted | Aug 30, 2004 |
| Last update posted | Nov 7, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: